Pyridone-substituted-dihydropyrazolopyrimidinone derivative
US8329711B2 · kind B2 · utility
4Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2008 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Mar 23, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of general formula (I-0):wherein R1, R2, R3, R4, R5, R6, R7a, R8a, X, and Y are as defined herein.Compounds of the invention have, based on excellent Wee1 kinase-inhibitory effect, a cell growth-inhibitory effect and an additive/synergistic effect with any other anticancer agent, and are therefore useful in the field of medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.